Corvex Total Revenue increased by 1059.1% to $510.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 147.6%, from $206.00K to $510.00K. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenue| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $852.00K | $23.00K | $50.00K | $111.00K | $206.00K | $103.00K | $80.00K | $44.00K | $510.00K |
| QoQ Change | — | -97.3% | +117.4% | +122.0% | +85.6% | -50.0% | -22.3% | -45.0% | >999% |
| YoY Change | — | — | — | — | -75.8% | +347.8% | +60.0% | -60.4% | +147.6% |
| Segment | Q1 '26 |
|---|---|
| Revenue AI Platform And Services | $475.00K |
| Revenue Connected Devices And Services | $35.00K |
| Total | $510.00K |
| Segment | Q1 '24 | Q1 '25 |
|---|---|---|
| Chief Operating Decision Maker | $852.00K | $206.00K |
| Total | $852.00K | $206.00K |
Chief Operating Decision Maker was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | FY'25 |
|---|---|
| Segment Reporting | $433.00K |
| Total | $433.00K |
All segment values are derived from annual filings.